These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30797078)

  • 1. Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and/or neonatal rash: Evidence from the Italian cohort of 61 patients with elevated IgE.
    Lorenzini T; Giacomelli M; Scomodon O; Cortesi M; Rivellini V; Dotta L; Soresina A; Dellepiane RM; Carrabba M; Cossu F; Cancrini C; Specchia F; Giardino G; Pignata C; Plebani A; Pietrogrande MC; Badolato R;
    J Allergy Clin Immunol Pract; 2019; 7(6):2072-2075.e4. PubMed ID: 30797078
    [No Abstract]   [Full Text] [Related]  

  • 2. Autosomal Dominant Hyper-IgE Syndrome Without Significantly Elevated IgE.
    Larsen CS; Christiansen M; Mogensen TH
    J Clin Immunol; 2019 Nov; 39(8):827-831. PubMed ID: 31468318
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
    Xie L; Hu X; Li Y; Zhang W; Chen L
    Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-IgE syndrome with a novel mutation of the STAT3 gene.
    Minakawa S; Tanaka H; Kaneko T; Matsuzaki Y; Kono M; Akiyama M; Minegishi Y; Sawamura D
    Clin Exp Dermatol; 2016 Aug; 41(6):687-9. PubMed ID: 27333819
    [No Abstract]   [Full Text] [Related]  

  • 6. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
    Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
    Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
    Alcántara-Montiel JC; Vega-Torres BI
    Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis.
    Frede N; Rojas-Restrepo J; Caballero Garcia de Oteyza A; Buchta M; Hübscher K; Gámez-Díaz L; Proietti M; Saghafi S; Chavoshzadeh Z; Soler-Palacin P; Galal N; Adeli M; Aldave-Becerra JC; Al-Ddafari MS; Ardenyz Ö; Atkinson TP; Kut FB; Çelmeli F; Rees H; Kilic SS; Kirovski I; Klein C; Kobbe R; Korganow AS; Lilic D; Lunt P; Makwana N; Metin A; Özgür TT; Karakas AA; Seneviratne S; Sherkat R; Sousa AB; Unal E; Patiroglu T; Wahn V; von Bernuth H; Whiteford M; Doffinger R; Jouhadi Z; Grimbacher B
    J Clin Immunol; 2021 Nov; 41(8):1804-1838. PubMed ID: 34390440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.
    Sundin M; Tesi B; Sund Böhme M; Bryceson YT; Pütsep K; Chiang SC; Thunberg S; Winiarski J; Wikström AC
    J Clin Immunol; 2014 May; 34(4):469-77. PubMed ID: 24627079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyper IgE syndrome: anaphylaxis in a patient carrying the N567D STAT3 mutation.
    Merli P; Novara F; Montagna D; Benzo S; Tanzi M; Turin I; De Amici M; Merli A; Zuffardi O; Marseglia GL
    Pediatr Allergy Immunol; 2014 Aug; 25(5):503-5. PubMed ID: 24628715
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.
    Grimbacher B; Holland SM; Gallin JI; Greenberg F; Hill SC; Malech HL; Miller JA; O'Connell AC; Puck JM
    N Engl J Med; 1999 Mar; 340(9):692-702. PubMed ID: 10053178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
    Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
    Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronological changes of skin eruptions toward cold abscess formation in hyper-immunoglobulin E syndrome.
    Fukui R; Hidaka T; Terui H; Rikiishi T; Sasahara Y; Kagimoto Y; Kusakari Y; Yamasaki K; Aiba S
    J Dermatol; 2021 Jul; 48(7):e316-e317. PubMed ID: 33960444
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
    Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
    Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
    Kumánovics A; Perkins SL; Gilbert H; Cessna MH; Augustine NH; Hill HR
    J Clin Immunol; 2010 Nov; 30(6):886-93. PubMed ID: 20859667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
    Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H
    Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Job's syndrome and miliary tuberculosis].
    Gamberale A; Moreira I; Bartoletti B; Cruz V; Bezrodnik L; Alberti F; Catro Zorrilla L; Palmero D
    Medicina (B Aires); 2014; 74(4):311-4. PubMed ID: 25188660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [STAT3 mutation in a child with hyper-IgE syndrome and incomplete clinical features].
    Szaflarska A; Rutkowska-Zapała M; Pituch-Noworolska A; Siedlar M
    Przegl Lek; 2015; 72(12):787-90. PubMed ID: 27024962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009-2018).
    Xiang Q; Zhang L; Liu X; Wang S; Wang T; Xiao M; Zhao X; Jiang L
    Scand J Immunol; 2020 Jun; 91(6):e12885. PubMed ID: 32248557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hyper-IgE syndromes.
    Freeman AF; Holland SM
    Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.